Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02089555 · ClinicalTrials.gov registry record
African American Alzheimer's Progression Markers - CSF and Neuro-Imaging
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 135
- Enrollment target
NCT02089555 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 135 participants.
The verdict
NCT02089555 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 135 participants
- Enrollment target
Study Summary
African Americans are twice as likely to develop Alzheimer's disease as white Americans, but few African Americans are enrolled in large Alzheimer's biomarker studies. The current proposal aims to determine the influence of Alzheimer's disease and vascular disease on memory and aging in African Americans through modern biomarkers (spinal fluid, MRI, and amyloid imaging), and how these may differ between African Americans and white Americans in preparation for a large multi-center study of aging in African American.
Interventions
- PROCEDURE Magnetic Resonance Imaging (MRI)
- PROCEDURE Blood draw
- PROCEDURE Lumbar puncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02089555
The ClinicalTrials.gov registry entry for NCT02089555 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT02089555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02089555 about?
NCT02089555 is a clinical study titled "African American Alzheimer's Progression Markers - CSF and Neuro-Imaging". African Americans are twice as likely to develop Alzheimer's disease as white Americans, but few African Americans are enrolled in large Alzheimer's biomarker studies. The current proposal aims to determine the influence of Alzheimer's disease and vascular disease on memory and aging in African Amer...
What is the current status of trial NCT02089555?
This trial is currently completed. The enrollment target is 135 participants. The study started on 2013-09. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02089555?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (PROCEDURE), Blood draw (PROCEDURE), Lumbar puncture (PROCEDURE).
Who is sponsoring clinical trial NCT02089555?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.